• PRINT SUBSCRIBERS |
  • SUBSCRIBE |
  • Login
  • My Account
  • (FREE ARTICLE)
weather icon

4

P/CLOUDY

TOKYO (12 a.m.)

  • Markets
  • 104 ¥/$ (5 p.m.)

The Japan Times

BioNTech

  • Login
  • SUBSCRIBE
  • My Account
  • TODAY'S PRINT EDITION ≫
  • PRINT SUBSCRIBERS ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Reader Mail
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
mRNA vaccines could vanquish COVID-19 today, cancer tomorrow

Commentary / World Jan 13, 2021

mRNA vaccines could vanquish COVID-19 today, cancer tomorrow

by Andreas Kluth

Therein lies mRNA’s bigger promise: It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.

Breakfast, freezers, Lego: On the vaccine trail in Germany

World / Science & Health Dec 27, 2020

Breakfast, freezers, Lego: On the vaccine trail in Germany

As BioNTech and other pharmaceutical companies leapt into action in search of the winning formula, Germany's army of manufacturing and logistics experts would soon prove crucial.

How vaccine-makers are preparing for mutant coronavirus strains

World / Science & Health Dec 23, 2020

How vaccine-makers are preparing for mutant coronavirus strains

by Tim Loh

Drugmakers have said they could reset the COVID-19 shot to counter a new strain within just six weeks.

EU clears Pfizer COVID-19 vaccine for first inoculations

World Dec 22, 2020

EU clears Pfizer COVID-19 vaccine for first inoculations

Preparations for the vaccine roll-out come as the identification of a highly infectious new strain of the coronavirus in Britain caused chaos across the region.

U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions

World / Science & Health Dec 10, 2020

U.K. issues anaphylaxis warning on Pfizer vaccine after adverse reactions

Britain began mass vaccinating its population on Tuesday, part of a global drive that poses one of the biggest logistical challenges in peacetime history.

With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout

World Dec 6, 2020

With Pfizer's COVID-19 shot, Britain prepares for world-first vaccine rollout

Britain gave emergency use approval for the vaccine last week — jumping ahead in the global race to begin the most crucial mass inoculation program in history.

Why the U.K. approved a COVID-19 vaccine first

World / Science & Health Dec 3, 2020

Why the U.K. approved a COVID-19 vaccine first

by Benjamin Mueller

Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.

U.K. approves Pfizer-BioNTech vaccine for rollout from 'next week'

World Dec 2, 2020

U.K. approves Pfizer-BioNTech vaccine for rollout from 'next week'

After months of "rigorous" trials and thorough analysis of the data, the U.K. regulator "concluded that the vaccine has met its strict standards of safety, quality and effectiveness."

A triumph of German innovation and immigration

Commentary / World Dec 1, 2020

A triumph of German innovation and immigration

by Hans-werner Sinn

The great advantage of BioNTech's approach is that it allows for the production of more than one billion vaccine doses within the space of just a few months.

U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine

World / Science & Health Nov 29, 2020

U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine

The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as soon as early next week, according to a person familiar ...

Pfizer vaccine's safety milestone is just the beginning

Commentary Nov 22, 2020

Pfizer vaccine's safety milestone is just the beginning

by Therese Raphael

As new vaccines look set for regulatory approval, managing the follow-up on adverse drug reactions will be critical for any vaccination program to be successful.

Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'

World / Science & Health Nov 19, 2020

Pfizer-BioNTech coronavirus vaccine deliveries could start 'before Christmas'

Final trial results showed the vaccine had a 95% success rate and no serious side effects, the drugmakers said.

VIEW OLDER ARTICLES

  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Kamala Harris will make history. So will her ‘big, blended’ family.
    Vice President-elect Kamala Harris and her family watch fireworks after addressing supporters in Wilmington, Delaware, on Nov. 7. As Harris ascends to a barrier-breaking role, with her loved ones looking on, millions of Americans will see a more expansive version of the American family staring back at them.
  • Japan suicides jumped 16% in COVID-19 second wave after drop in first
    A handful of shoppers walk through the Nishiki market in Kyoto on Thursday. Suicide rates in Japan have jumped in the second wave of the pandemic, particularly among women and children, even though they fell in the first wave when the government offered generous handouts to people, a survey has found.
  • China eyes bolstering control of rare earths as national strategy
    Neodymium is displayed at the Inner Mongolia Baotou Steel Rare-Earth Hi-Tech Co. factory in Baotou, Inner Mongolia, China, in May 2010.
  • The true cost of the climate crisis on Japan
    Some parts of Nagano Prefecture were heavily damaged by Typhoon Hagibis in October 2019.
  • Hopes for Tokyo’s Summer Olympics growing dim
    A man wearing a mask walks past a poster featuring Tokyo 2020 mascot Miraitowa in Tokyo on June 4, 2020.
  • Chuck Mills, who inspired Japan's college football to flourish, dies at 92

    Thumbnail image
  • 49-year-old university exam-taker arrested over refusal to leave toilet

    Thumbnail image
  • Quarantined Kei Nishikori struggling to train for Australian Open

    Thumbnail image
  • Vaccine disparities raise alarm as coronavirus variants multiply

    Thumbnail image
  • Japan scrambles to roll out vaccine, but how many people will get the shot?

    Thumbnail image
COVID-19 banner

PODCAST

  • DEEP DIVE

    Episode 77: When will Japan get a vaccine for COVID-19?

    LAST UPDATED: Jan 13, 2021

JAPAN NETWORK UPDATES

  • Directory of who’s who in the world of business in Japan

    LAST UPDATED: Jun 8, 2020

    JAPAN NETWORK UPDATES
Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha Jobs Study in Japan JT for Women JT Bookclub Japanese School Directory
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Reader Mail
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Privacy Policy
  • Link Policy
  • Reprints
  • FAQs
  • Support
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times